Screener
Prime Medicine PRME Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Prime Medicine’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053883
| (in thousands, except share and per share amounts) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Operating expenses: | ||||
| Research and development | 33,397 | 41,375 | 67,502 | 81,937 |
| General and administrative | 11,042 | 13,117 | 28,447 | 26,401 |
| Total operating expenses | 44,439 | 54,492 | 95,949 | 108,338 |
| Loss from operations | (43,285) | (53,377) | (93,939) | (105,769) |
| Other income: | ||||
| Interest income | 788 | 743 | 1,809 | 1,925 |
| Accretion (amortization) of investments | 333 | 530 | 793 | 869 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Prime Medicine's other operating expenses?
- Prime Medicine (PRME) reported other operating expenses of $44.44M in Q2 2026.
- How has Prime Medicine's other operating expenses changed year-over-year?
- Prime Medicine's other operating expenses decreased by 18.4% year-over-year, from $54.49M to $44.44M.
- What is the long-term trend for Prime Medicine's other operating expenses?
- Over 3 years (2022 to 2025), Prime Medicine's other operating expenses has grown at a 22.3% compound annual growth rate (CAGR), from $116.54M to $212.98M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.
Ask your AI about Prime Medicine's other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude